Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김신규 | - |
dc.date.accessioned | 2018-02-17T09:17:30Z | - |
dc.date.available | 2018-02-17T09:17:30Z | - |
dc.date.issued | 2012-04 | - |
dc.identifier.citation | Clinica Chimica Acta, 413, 7-8, 831-832 | en_US |
dc.identifier.issn | 0009-8981 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0009898112000435 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11754/37930 | - |
dc.description.abstract | Background: To find out whether serum level of anti-cyclic citrullinated peptides (anti-CCP) could be useful inthe diagnosis of rheumatoid arthritis (RA). Methods: The study was performed against 1972 patients who visited Hanyang University Medical Center and were tested positive for anti-CCP. Results: When test results were classified into 6 groups according to the anti-CCP level, diagnostic rates of RA in each group were distributed from 73.6% to 77.2%. The increase of serum level did not have any correlation with the diagnostic rate of RA. Conclusions: The level of serum anti-CCP was not useful in the diagnosis of RA. ⓒ 2012 Elsevier | en_US |
dc.language.iso | other | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Anti-CCP | en_US |
dc.subject | ELISA | en_US |
dc.subject | Rheumatoid arthritis | en_US |
dc.subject | Diagnosis | en_US |
dc.title | Is serum anti-cyclic citrullinated peptide level useful in the diagnosis of rheumatoid arthritis? | en_US |
dc.type | Article | en_US |
dc.relation.no | 7-8 | - |
dc.relation.volume | 413 | - |
dc.identifier.doi | 10.1016/j.cca.2012.01.022 | - |
dc.relation.page | 831-832 | - |
dc.relation.journal | CLINICA CHIMICA ACTA | - |
dc.contributor.googleauthor | Kim, Duck-An | - |
dc.contributor.googleauthor | Kim, Think-You | - |
dc.relation.code | 2012201963 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | tykim | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.